Developer docs
API playgroundTry for free, no card

Search company profiles

TVM Capital Healthcare

Full company profile

uuid0000622

Namestring
TVM Capital Healthcare
Legal namestring
TVM Capital Healthcare Partners Limited
Company typeenum
Private
Founded yearint
2010
Descriptiontext

TVM Capital Healthcare is a healthcare-focused private equity and growth capital firm operating across Southeast Asia and the MENA region, with headquarters in Singapore, a regional office in the Dubai International Financial Centre, and an investment office in Riyadh. The firm has nearly 40 years of global healthcare investing experience and more than 15 years focused on emerging markets, deploying capital through dedicated sector funds — the USD 254 million TVM Healthcare Afiyah Fund (closed 2024, Saudi Arabia) and the USD 150 million TVM Healthcare Southeast Asia Fund (first close September 2025) — collectively managing and advising nearly USD 500 million in committed capital. Its investment model is that of an investor-operator rather than a passive capital provider: alongside capital, TVM contributes hands-on clinical, operational, training, and management support through the TVM Operations Group and a network of more than 10 Operating Partners and 25 Senior Advisors, including former health ministers, hospital CEOs, and clinical entrepreneurs.

The firm invests as lead investor in selected healthcare verticals — post-acute care, rehabilitation, long-term care, home healthcare, mental health, women's health, oncology, longevity and precision medicine, eyecare, and local pharmaceutical manufacturing — targeting underpenetrated market segments in Saudi Arabia, UAE, Qatar, Oman, Kuwait, Singapore, Vietnam, Thailand, Philippines, Indonesia, and Malaysia. Notable portfolio companies include Baraya Extended Care, Manzil Healthcare Services, Boston Oncology Arabia, neurocare, Human Longevity Inc., and Alina Vision. Cross-border partnerships with Harvard-affiliated Spaulding Rehabilitation Network, Siemens Healthineers, IFC, NUS Saw Swee Hock School of Public Health, and PwC enable transfer of clinical protocols, care models, and accreditation pathways (JCI, CARF) into target markets. TVM measures and reports impact using GIIN IRIS+ metrics and the IFC Ethical Principles in Healthcare (EPiHC), is a UN PRI signatory, and is a member of GPCA, 2X Global, and GIIN.

The firm's revenue model is that of a traditional private equity manager: it earns management fees on committed capital (typically 1.5–2.0% annually) and carried interest on realized gains. Historical exits demonstrate top-quartile returns — CMRC was sold to Amanat Holdings for USD 232 million in March 2021 at a 4.6x return (28.0% Gross IRR, 19.7% Net IRR, 2.4x DPI), and ProVita International Medical Center was exited in 2015 at a 10.7x return. Fundraising is sourced from a diversified institutional LP base including development finance institutions (Invest International as cornerstone, IFC, ADI), sovereign and quasi-sovereign investors (Olayan, SEDCO, ANB Capital, SVC), and family offices. The firm employs 11–50 staff across investment, operating partner, and platform operations functions, with the Platform Operations team headquartered in DMCC, Dubai.

Short descriptiontext

TVM Capital Healthcare is a healthcare-focused private equity and growth capital firm investing across Southeast Asia and the MENA region through dedicated sector funds, combining capital with hands-on operating support to build specialty healthcare platforms.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDubai, United Arab Emirates
HQ citystring
Dubai
HQ countrystring
United Arab Emirates
HQ regionstring
Middle East
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare private equity, growth capital investing, healthcare fund management, emerging market healthcare, healthcare investor-operator
Industry2 codes
1Healthcare & Life Sciences Growth Equity
CodeFSANACABPrimaryYes
2Private/For-Profit Hospital Systems
CodeHLAFAAAFPrimaryNo
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • Funds, Trusts, and Other Financial Vehicles525
SIC code1 code
  • Investment Advice6282
Product category
Healthcare Private Equity / Investment Management
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Fund Management Fees and Carried Interest
TypeManaged Services
Description

TVM Capital Healthcare generates revenue through managing private equity funds for institutional investors, earning management fees on committed capital and carried interest (performance fees) on realized gains. Funds managed include the TVM Healthcare Afiyah Fund (USD 254 million, Saudi-focused) and the TVM Healthcare Southeast Asia Fund (USD 150 million target, first close September 2025).

tvmcapitalhealthcare.com
2Co-investment Returns
TypeLicensing Royalties
Description

The firm co-invests its own capital alongside fund LPs, generating direct investment returns alongside fee income. The CMRC exit generated a 4.6x return on capital invested; ProVita exit generated a 10.7x return.

tvmcapitalhealthcare.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1TVM Healthcare Institute
Description

A think tank network of top executives, key influencers, and visionaries in the healthcare industry, with primary mission of driving transformation towards innovation, sustainability, and increased access to quality care.

tvmcapitalhealthcare.com
Core offering1 text field

TVM Capital Healthcare is a private equity and growth capital firm that invests in transformational healthcare companies across Southeast Asia and the MENA region. It manages dedicated healthcare funds (TVM Healthcare Afiyah Fund, USD 254M; TVM Healthcare Southeast Asia Fund, USD 150M first close) and provides hands-on operational support to portfolio companies through the TVM Operations Group, combining capital deployment with operator expertise in post-acute care, rehabilitation, long-term care, home healthcare, mental health, longevity, and local pharmaceutical manufacturing.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • CMRC exit generated a 4.6x return on capital invested and 2.4x DPI (Distribution to Paid-In capital) with 28.0% Gross IRR / 19.7% Net IRR — Upper Quartile performance
+5 more records
Product overview1 text field

TVM Capital Healthcare is a private equity investor-operator focused on healthcare growth capital across Southeast Asia and the Middle East (MENA) region. The firm does not offer a unified technology product or SaaS platform; instead, it operates investment funds and provides operational advisory services to portfolio companies. The firm's investment vehicles include the USD 150 million TVM Healthcare Southeast Asia Fund and the USD 254 million TVM Healthcare Afiyah Fund (Saudi Arabia-focused). The firm offers healthcare advisory services through the TVM Operations Group, which supports portfolio companies with operational expertise, and hosts the TVM Healthcare Institute as a think tank network. The company's portfolio companies (which are separate legal entities TVM has invested in) include: Cambridge Medical & Rehabilitation Center (post-acute care and rehabilitation), Manzil Healthcare Services (home care and disease management), Baraya Extended Care (long-term care in Saudi Arabia), neurocare (mental health treatment including TMS devices), Boston Oncology Arabia (pharmaceutical manufacturing), Human Longevity, Inc. (longevity and precision medicine), and Alina Vision (eye care in Vietnam).

Product and service4 records
1TVM Healthcare Afiyah Fund
CategoryPrivate Equity Fund (Healthcare)
Description

Dedicated healthcare private equity fund for Saudi Arabia, providing growth capital and operational support to healthcare companies aligned with the Kingdom's Vision 2030 healthcare transformation program. Targeted at investors seeking exposure to specialty care, extended care, mental health, local pharmaceutical manufacturing, and digital health in the Kingdom.

2TVM Healthcare Southeast Asia Fund
CategoryPrivate Equity Fund (Healthcare)
Description

Third-generation dedicated healthcare private equity fund for Southeast Asia, providing growth capital to healthcare companies in underpenetrated market segments including post-acute and rehabilitation services, women's health, diabetic and oncology care, and local manufacturing of essential pharmaceuticals. Cornerstone-invested by Invest International and supported by cross-border partnerships with Harvard-affiliated teaching hospitals and European medtech companies.

3TVM Operations Group
CategoryHealthcare Advisory Services
Description

Healthcare advisory platform operating through TVM Operations Group DMCC (Dubai), providing clinical, training, and management support to portfolio companies to help increase capacity and improve quality of care. Delivered to healthcare companies within the firm's investment portfolio across MENA.

4TVM Healthcare Institute
CategoryIndustry Network / Think Tank
Description

Invitation-only think tank network bringing together top executives, key influencers, and visionaries in the healthcare industry. Mission focuses on driving transformation towards innovation, sustainability, and access to quality affordable healthcare. Knowledge Partner: NUS Saw Swee School of Public Health; Technology Partner: Siemens Healthineers. Inaugural event held in Singapore (September 2022) and KSA Think Tank in Riyadh (June 2024).

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-07
Description

PwC partnered with TVM Capital Healthcare on a joint whitepaper titled 'Expanding the Scope of Extended Care to Ease the Growing Healthcare Burden,' examining how targeted private-sector investment and specialized care outside traditional hospital settings can reinforce national health priorities across the Middle East.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-09-23
Description

Siemens Healthineers serves as Technology Partner for the TVM Healthcare Institute, collaborating with TVM Capital Healthcare on events and thought leadership to bring together early-stage investors and local entrepreneurs in creating successful healthcare business cases and market access in Southeast Asia.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-09-23
Description

NUS Saw Swee School of Public Health serves as Knowledge Partner for the TVM Healthcare Institute think tank network.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Spaulding Rehabilitation Network, affiliated with Harvard Medical School, has been a clinical partnership for TVM Capital Healthcare portfolio companies including CMRC and Manzil Healthcare. The partnership enables development of clinical protocols, quality systems, and international best practices in rehabilitation and post-acute care, contributing to JCI and CARF accreditation for portfolio companies.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

IFC sponsored and participated in TVM Healthcare Institute events as part of the ecosystem of private investors, technology partners, and development funds working to improve healthcare access in Southeast Asia.

Strategic tierCoreTypeOthers
Description

JCI accreditation was achieved by TVM Capital Healthcare portfolio companies including CMRC (post-acute care) and Manzil Healthcare (home care) as a first stand-alone home health provider — demonstrating international best clinical standards.

7Commission on Accreditation of Rehabilitation Facilities (CARF)
Strategic tierCoreTypeOthers
Description

CARF accreditation was achieved by CMRC, demonstrating international rehabilitation care standards and best clinical practices alongside JCI accreditation.

tvmcapitalhealthcare.com
Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Singapore-based healthcare growth equity firm investing across South and Southeast Asia. Closest comparable to TVM Capital Healthcare by virtue of overlapping SEA mandate, healthcare-only thesis, growth-equity stage focus, and emerging-market operating model.

TypeBroad incumbent
Description

Global healthcare-dedicated investment platform managing multi-billion AUM across PE, growth, and royalties. Comparable in healthcare-only specialization and growth-stage focus, but materially larger and broader geographically than TVM's emerging-market mandate.

TypeDirect peer
Description

Emerging-markets growth investor with a strong healthcare and financial-services focus across Africa and Asia. Directly comparable to TVM in impact-led, emerging-market growth equity investing with measurable ESG outcomes.

TypeDirect peer
Description

Healthcare-focused growth equity firm investing in commercial-stage companies across emerging markets. Direct peer to TVM in healthcare-only emerging-markets PE with growth-stage deal focus and operating-partner model.

TypeEmerging player
Description

India-focused healthcare VC and growth fund with thematic bets across pharma, medtech, and digital health. Comparable to TVM in healthcare specialization and emerging-market focus, but earlier stage and India-only.

TypeBroad incumbent
Description

Global emerging-markets private equity investor with a sizable healthcare allocation across Africa, Asia, and Latin America. Comparable as an emerging-markets PE generalist with healthcare exposure, though healthcare is one of several sectors rather than a dedicated focus.

TypeRegional player
Description

Abu Dhabi-based alternative asset manager with private equity and credit strategies across the MENA region. Regional comparable to TVM's MENA footprint, though Gulf Capital is sector-generalist and Gulf-focused rather than healthcare-dedicated.

TypeOthers
Description

UAE-listed investment company focused on healthcare and education across the GCC. Indirectly comparable as a MENA-based capital partner to TVM, notably as the acquirer of CMRC in 2021 for $232M, illustrating overlapping investment universes.

TypeBroad incumbent
Description

Global alternative asset manager with a dedicated healthcare vertical across buyout and growth. Comparable to TVM in growth-stage healthcare investing, but at materially greater scale and global reach rather than emerging-market focus.

TypeBroad incumbent
Description

Global PE firm with a dedicated healthcare strategic growth platform investing in commercial-stage healthcare companies. Broad-incumbent comparable to TVM in growth-stage healthcare exposure, but globally diversified and multi-sector.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance13 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment13 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

TVM Capital Healthcare

Healthcare Private Equity / Investment Managementtvmcapitalhealthcare.com

TVM Capital Healthcare is a healthcare-focused private equity and growth capital firm investing across Southeast Asia and the MENA region through dedicated sector funds, combining capital with hands-on operating support to build specialty healthcare platforms.

What TVM Capital Healthcare does

TVM Capital Healthcare is a healthcare-focused private equity and growth capital firm operating across Southeast Asia and the MENA region, with headquarters in Singapore, a regional office in the Dubai International Financial Centre, and an investment office in Riyadh. The firm has nearly 40 years of global healthcare investing experience and more than 15 years focused on emerging markets, deploying capital through dedicated sector funds — the USD 254 million TVM Healthcare Afiyah Fund (closed 2024, Saudi Arabia) and the USD 150 million TVM Healthcare Southeast Asia Fund (first close September 2025) — collectively managing and advising nearly USD 500 million in committed capital. Its investment model is that of an investor-operator rather than a passive capital provider: alongside capital, TVM contributes hands-on clinical, operational, training, and management support through the TVM Operations Group and a network of more than 10 Operating Partners and 25 Senior Advisors, including former health ministers, hospital CEOs, and clinical entrepreneurs.

The firm invests as lead investor in selected healthcare verticals — post-acute care, rehabilitation, long-term care, home healthcare, mental health, women's health, oncology, longevity and precision medicine, eyecare, and local pharmaceutical manufacturing — targeting underpenetrated market segments in Saudi Arabia, UAE, Qatar, Oman, Kuwait, Singapore, Vietnam, Thailand, Philippines, Indonesia, and Malaysia. Notable portfolio companies include Baraya Extended Care, Manzil Healthcare Services, Boston Oncology Arabia, neurocare, Human Longevity Inc., and Alina Vision. Cross-border partnerships with Harvard-affiliated Spaulding Rehabilitation Network, Siemens Healthineers, IFC, NUS Saw Swee Hock School of Public Health, and PwC enable transfer of clinical protocols, care models, and accreditation pathways (JCI, CARF) into target markets. TVM measures and reports impact using GIIN IRIS+ metrics and the IFC Ethical Principles in Healthcare (EPiHC), is a UN PRI signatory, and is a member of GPCA, 2X Global, and GIIN.

The firm's revenue model is that of a traditional private equity manager: it earns management fees on committed capital (typically 1.5–2.0% annually) and carried interest on realized gains. Historical exits demonstrate top-quartile returns — CMRC was sold to Amanat Holdings for USD 232 million in March 2021 at a 4.6x return (28.0% Gross IRR, 19.7% Net IRR, 2.4x DPI), and ProVita International Medical Center was exited in 2015 at a 10.7x return. Fundraising is sourced from a diversified institutional LP base including development finance institutions (Invest International as cornerstone, IFC, ADI), sovereign and quasi-sovereign investors (Olayan, SEDCO, ANB Capital, SVC), and family offices. The firm employs 11–50 staff across investment, operating partner, and platform operations functions, with the Platform Operations team headquartered in DMCC, Dubai.

TVM Capital Healthcare firmographics

Firmographics
Name
TVM Capital Healthcare
Legal name
TVM Capital Healthcare Partners Limited
Website
https://tvmcapitalhealthcare.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
11–50 employees
Short description
TVM Capital Healthcare is a healthcare-focused private equity and growth capital firm investing across Southeast Asia and the MENA region through dedicated sector funds, combining capital with hands-on operating support to build specialty healthcare platforms.
Ownership category
akta.pro rank

TVM Capital Healthcare industry classification

Industry
Product category
Healthcare Private Equity / Investment Management
NAICS
Portfolio Management and Investment Advice (523940), Funds, Trusts, and Other Financial Vehicles (525)
SIC
Investment Advice (6282)
akta.pro primary industry
Healthcare & Life Sciences Growth Equity (FSANACAB)
akta.pro secondary industry
Private/For-Profit Hospital Systems (HLAFAAAF)

Keywords

  • Healthcare private equity
  • Growth capital investing
  • Healthcare fund management
  • Emerging market healthcare
  • Healthcare investor-operator

Where TVM Capital Healthcare is headquartered

Location

Headquarters

HQ city
Dubai
HQ country
United Arab Emirates
HQ region
Middle East

Offices4 records

Markets served

TVM Capital Healthcare business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Fund Management Fees and Carried Interest: TVM Capital Healthcare generates revenue through managing private equity funds for institutional investors, earning management fees on committed capital and carried interest (performance fees) on realized gains. Funds managed include the TVM Healthcare Afiyah Fund (USD 254 million, Saudi-focused) and the TVM Healthcare Southeast Asia Fund (USD 150 million target, first close September 2025).
  2. Co-investment Returns: The firm co-invests its own capital alongside fund LPs, generating direct investment returns alongside fee income. The CMRC exit generated a 4.6x return on capital invested; ProVita exit generated a 10.7x return.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

TVM Capital Healthcare product offering

Product offering

Core offering

TVM Capital Healthcare is a private equity and growth capital firm that invests in transformational healthcare companies across Southeast Asia and the MENA region. It manages dedicated healthcare funds (TVM Healthcare Afiyah Fund, USD 254M; TVM Healthcare Southeast Asia Fund, USD 150M first close) and provides hands-on operational support to portfolio companies through the TVM Operations Group, combining capital deployment with operator expertise in post-acute care, rehabilitation, long-term care, home healthcare, mental health, longevity, and local pharmaceutical manufacturing.

Product overview

TVM Capital Healthcare is a private equity investor-operator focused on healthcare growth capital across Southeast Asia and the Middle East (MENA) region. The firm does not offer a unified technology product or SaaS platform; instead, it operates investment funds and provides operational advisory services to portfolio companies. The firm's investment vehicles include the USD 150 million TVM Healthcare Southeast Asia Fund and the USD 254 million TVM Healthcare Afiyah Fund (Saudi Arabia-focused). The firm offers healthcare advisory services through the TVM Operations Group, which supports portfolio companies with operational expertise, and hosts the TVM Healthcare Institute as a think tank network. The company's portfolio companies (which are separate legal entities TVM has invested in) include: Cambridge Medical & Rehabilitation Center (post-acute care and rehabilitation), Manzil Healthcare Services (home care and disease management), Baraya Extended Care (long-term care in Saudi Arabia), neurocare (mental health treatment including TMS devices), Boston Oncology Arabia (pharmaceutical manufacturing), Human Longevity, Inc. (longevity and precision medicine), and Alina Vision (eye care in Vietnam).

Differentiator

Problem solved

Functional benefit

Brands

  • TVM Healthcare Institute: A think tank network of top executives, key influencers, and visionaries in the healthcare industry, with primary mission of driving transformation towards innovation, sustainability, and increased access to quality care.

Products and services

  • TVM Healthcare Afiyah Fund Dedicated healthcare private equity fund for Saudi Arabia, providing growth capital and operational support to healthcare companies aligned with the Kingdom's Vision 2030 healthcare transformation program. Targeted at investors seeking exposure to specialty care, extended care, mental health, local pharmaceutical manufacturing, and digital health in the Kingdom.
  • TVM Healthcare Southeast Asia Fund Third-generation dedicated healthcare private equity fund for Southeast Asia, providing growth capital to healthcare companies in underpenetrated market segments including post-acute and rehabilitation services, women's health, diabetic and oncology care, and local manufacturing of essential pharmaceuticals. Cornerstone-invested by Invest International and supported by cross-border partnerships with Harvard-affiliated teaching hospitals and European medtech companies.
  • TVM Operations Group Healthcare advisory platform operating through TVM Operations Group DMCC (Dubai), providing clinical, training, and management support to portfolio companies to help increase capacity and improve quality of care. Delivered to healthcare companies within the firm's investment portfolio across MENA.
  • TVM Healthcare Institute Invitation-only think tank network bringing together top executives, key influencers, and visionaries in the healthcare industry. Mission focuses on driving transformation towards innovation, sustainability, and access to quality affordable healthcare. Knowledge Partner: NUS Saw Swee School of Public Health; Technology Partner: Siemens Healthineers. Inaugural event held in Singapore (September 2022) and KSA Think Tank in Riyadh (June 2024).

Quantifiable outcome

  • CMRC exit generated a 4.6x return on capital invested and 2.4x DPI (Distribution to Paid-In capital) with 28.0% Gross IRR / 19.7% Net IRR — Upper Quartile performance
  • +5 more outcomes

Companies that use TVM Capital Healthcare

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles2 records

TVM Capital Healthcare technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

TVM Capital Healthcare partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • PwCcoreStrategic or Co-development Partner · 7 September 2025PwC partnered with TVM Capital Healthcare on a joint whitepaper titled 'Expanding the Scope of Extended Care to Ease the Growing Healthcare Burden,' examining how targeted private-sector investment and specialized care outside traditional hospital settings can reinforce national health priorities across the Middle East.
  • Siemens HealthineerscoreStrategic or Co-development Partner · 23 September 2022Siemens Healthineers serves as Technology Partner for the TVM Healthcare Institute, collaborating with TVM Capital Healthcare on events and thought leadership to bring together early-stage investors and local entrepreneurs in creating successful healthcare business cases and market access in Southeast Asia.
  • NUS Saw Swee School of Public HealthminorStrategic or Co-development Partner · 23 September 2022NUS Saw Swee School of Public Health serves as Knowledge Partner for the TVM Healthcare Institute think tank network.
  • Spaulding Rehabilitation Network (Harvard Medical Teaching Affiliate)coreStrategic or Co-development PartnerSpaulding Rehabilitation Network, affiliated with Harvard Medical School, has been a clinical partnership for TVM Capital Healthcare portfolio companies including CMRC and Manzil Healthcare. The partnership enables development of clinical protocols, quality systems, and international best practices in rehabilitation and post-acute care, contributing to JCI and CARF accreditation for portfolio companies.
  • International Finance Corporation (IFC)minorStrategic or Co-development PartnerIFC sponsored and participated in TVM Healthcare Institute events as part of the ecosystem of private investors, technology partners, and development funds working to improve healthcare access in Southeast Asia.
  • Joint Commission International (JCI)coreOthersJCI accreditation was achieved by TVM Capital Healthcare portfolio companies including CMRC (post-acute care) and Manzil Healthcare (home care) as a first stand-alone home health provider — demonstrating international best clinical standards.
  • Commission on Accreditation of Rehabilitation Facilities (CARF)coreOthersCARF accreditation was achieved by CMRC, demonstrating international rehabilitation care standards and best clinical practices alongside JCI accreditation.

Scale indicators10 records

Recent moves9 records

Expansion highlights6 records

TVM Capital Healthcare competitors and assessment

Company assessment

Direct peers

  • Quadria Capital: Singapore-based healthcare growth equity firm investing across South and Southeast Asia. Closest comparable to TVM Capital Healthcare by virtue of overlapping SEA mandate, healthcare-only thesis, growth-equity stage focus, and emerging-market operating model.
  • LeapFrog Investments: Emerging-markets growth investor with a strong healthcare and financial-services focus across Africa and Asia. Directly comparable to TVM in impact-led, emerging-market growth equity investing with measurable ESG outcomes.
  • NaviMed Capital: Healthcare-focused growth equity firm investing in commercial-stage companies across emerging markets. Direct peer to TVM in healthcare-only emerging-markets PE with growth-stage deal focus and operating-partner model.

Broad incumbents

  • OrbiMed Advisors: Global healthcare-dedicated investment platform managing multi-billion AUM across PE, growth, and royalties. Comparable in healthcare-only specialization and growth-stage focus, but materially larger and broader geographically than TVM's emerging-market mandate.
  • Actis: Global emerging-markets private equity investor with a sizable healthcare allocation across Africa, Asia, and Latin America. Comparable as an emerging-markets PE generalist with healthcare exposure, though healthcare is one of several sectors rather than a dedicated focus.
  • Carlyle Group (Healthcare): Global alternative asset manager with a dedicated healthcare vertical across buyout and growth. Comparable to TVM in growth-stage healthcare investing, but at materially greater scale and global reach rather than emerging-market focus.
  • KKR (Healthcare Strategic Growth): Global PE firm with a dedicated healthcare strategic growth platform investing in commercial-stage healthcare companies. Broad-incumbent comparable to TVM in growth-stage healthcare exposure, but globally diversified and multi-sector.

Emerging players

  • HealthQuad: India-focused healthcare VC and growth fund with thematic bets across pharma, medtech, and digital health. Comparable to TVM in healthcare specialization and emerging-market focus, but earlier stage and India-only.

Regional players

  • Gulf Capital: Abu Dhabi-based alternative asset manager with private equity and credit strategies across the MENA region. Regional comparable to TVM's MENA footprint, though Gulf Capital is sector-generalist and Gulf-focused rather than healthcare-dedicated.

Others

  • Amanat Holdings: UAE-listed investment company focused on healthcare and education across the GCC. Indirectly comparable as a MENA-based capital partner to TVM, notably as the acquirer of CMRC in 2021 for $232M, illustrating overlapping investment universes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

TVM Capital Healthcare social profiles

Digital presence

TVM Capital Healthcare compliance and trust

Trust signal

Compliance13 records

TVM Capital Healthcare financial estimates

Financial estimate

Revenue estimate

Valuation estimate

TVM Capital Healthcare leadership team

Management profile

Number of profiles

Profiles14 records

TVM Capital Healthcare funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

TVM Capital Healthcare M&A and investment

M&A and investment

M&A1 record

Investments13 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TVM Capital Healthcare

What does TVM Capital Healthcare do?

TVM Capital Healthcare is a private equity and growth capital firm that invests in transformational healthcare companies across Southeast Asia and the MENA region. It manages dedicated healthcare funds (TVM Healthcare Afiyah Fund, USD 254M; TVM Healthcare Southeast Asia Fund, USD 150M first close) and provides hands-on operational support to portfolio companies through the TVM Operations Group, combining capital deployment with operator expertise in post-acute care, rehabilitation, long-term care, home healthcare, mental health, longevity, and local pharmaceutical manufacturing.

Is TVM Capital Healthcare a public or private company?

TVM Capital Healthcare is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was TVM Capital Healthcare founded?

TVM Capital Healthcare was founded in 2010. It employs 11 to 50 people.

Where is TVM Capital Healthcare based?

TVM Capital Healthcare is headquartered in Dubai, United Arab Emirates, in the Middle East region.

How does TVM Capital Healthcare make money?

Two revenue lines are on record. Fund Management Fees and Carried Interest is the primary driver. The others are co-investment Returns.

Who are TVM Capital Healthcare's main competitors?

Direct peers on record are Quadria Capital, LeapFrog Investments and NaviMed Capital. Broad incumbents are OrbiMed Advisors, Actis, Carlyle Group (Healthcare) and KKR (Healthcare Strategic Growth). HealthQuad is listed as an emerging player. Gulf Capital is listed as a regional player. Amanat Holdings is listed as an others.

Does TVM Capital Healthcare have an API?

No public API is recorded for TVM Capital Healthcare.

What industry is TVM Capital Healthcare in?

TVM Capital Healthcare's product category is Healthcare Private Equity / Investment Management. Its primary akta.pro industry code is FSANACAB, Healthcare & Life Sciences Growth Equity, with a secondary code of HLAFAAAF, Private/For-Profit Hospital Systems. Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Financial PostAustralian Development Investments (ADI) backs TVM Capital Healthcare's Southeast Asia FundTVM Capital Healthcare announced that Australian Development Investments (ADI) has committed up to USD $8 million to the firm's Southeast Asia Fund through its Investing in Women window. The investment supports growth capital for healthcare companies expanding access to affordable, quality care while advancing women's leadership and patient outcomes in line with the 2X Criteria. The commitment reflects strong investor confidence in healthcare growth opportunities across Southeast Asia amid global economic uncertainty.FinancialContent Business PageAustralian Development Investments (ADI) backs TVM Capital Healthcare’s Southeast Asia FundAustralian Development Investments (ADI) has committed up to USD $8 million to TVM Capital Healthcare's Southeast Asia Fund through its Investing in Women window, supporting growth capital for healthcare companies that expand access to affordable, quality care while advancing women's leadership and patient outcomes. The commitment follows the fund's first closing in September 2025 and builds on TVM Capital Healthcare's nearly four decades of global healthcare investing experience and more than 15 years focused on emerging markets. The investment underscores strong investor confidence in the firm's strategy and track record, including its oversubscribed $254 million Afiyah Fund in the Middle East in 2024.GlobeNewswireAustralian Development Investments (ADI) backs TVM Capital Healthcare’s Southeast Asia FundAustralian Development Investments (ADI) has committed up to USD $8 million to TVM Capital Healthcare's Southeast Asia Fund through its Investing in Women initiative. The investment will support growth capital for healthcare companies expanding access to affordable, quality care while advancing women's leadership and workforce participation in line with the 2X Criteria. The commitment underscores investor confidence in the healthcare sector as a resilient investment destination amid economic uncertainty, and follows TVM Capital Healthcare's successful first closing of the fund in September 2025.ApexleadersThe Longevity Market Holds Strong Promise for InvestorsThe longevity industry, encompassing anti-aging therapies, gene sequencing, and complementary medicines, generated $65 billion in revenue in 2023 and is projected to reach $314 billion by 2030 with a forecasted compound annual growth rate of 25.2%. Human Longevity, Inc. completed a $39.8 million oversubscribed Series B funding round led by TVM Capital Healthcare, with participation from Panacea Venture and Emerging Technology Partners, signaling strong investor interest in the sector. Key growth drivers include AI-powered drug discovery, senolytic drug development, personalized health interventions, and expanding wellness markets like cryotherapy projected to reach $623 million by 2034.Pulse 2.0TVM Capital Healthcare: $150 Million Southeast Asia Fund LaunchedTVM Capital Healthcare closed its first $150 million Southeast Asia Fund, its third generation, with commitments from investors including Invest International. The fund targets underserved healthcare segments like post-acute care, women's health, and diabetes, and supports cross-border collaborations with US and European innovators.YahooTVM Capital Healthcare Announces First Closing of its USD 150 Million Southeast Asia FundTVM Capital Healthcare announced the first closing of its USD 150 million TVM Healthcare Southeast Asia Fund, the third generation of the firm's funds building on nearly 40 years of global healthcare investment experience. Commitments to the fund came from a broad group of institutional investors including cornerstone investor Invest International, founded by the Dutch government and FMO. The SEA Fund will focus on underpenetrated market segments in Southeast Asia, including post-acute and rehabilitation services, women's health, diabetic and oncology care, and local pharmaceutical manufacturing.PR NewswireTVM Capital Healthcare Announces First Closing of its USD 150 Million Southeast Asia FundTVM Capital Healthcare announced the first closing of its USD 150 million Southeast Asia Fund, with commitments from institutional investors including cornerstone investor Invest International, a Dutch government-linked development finance institution. The fund will invest in underpenetrated healthcare segments across Southeast Asia including post-acute and rehabilitation services, women's health, diabetes and oncology care, and local pharmaceutical manufacturing. The firm plans to scale local specialty care clinics into national and regional leaders while establishing cross-border partnerships with international healthcare innovators.PR NewswireTVM Capital Healthcare Appoints Former Vice Minister of Health in the Kingdom of Saudi Arabia, H.E. Hamad M. AlDhewalia, as Operating PartnerTVM Capital Healthcare has appointed H.E. Hamad M. AlDhewalia, former Vice Minister of Health Affairs in Saudi Arabia and former General Manager of Medical Services at Saudi Aramco, as Operating Partner, elevating him from his three-year tenure as Senior Partner. The appointment reinforces the firm's decade-long presence in Saudi Arabia and its alignment with Vision 2030's healthcare transformation agenda, as it expands investments in specialty care, digital health, and local pharmaceutical manufacturing. The firm manages nearly $500 million in committed capital, with its Afiyah Fund having closed at $254 million in 2024.StartupriseBaraya Extended Care Raises $124 Million in Series B Funding Led by TVM Capital HealthcareTVM Capital Healthcare led a $124 million Series B funding round for Baraya Extended Care in Saudi Arabia, which will be used to expand long-term care facilities amid rising healthcare needs. The company plans to open more hospitals and clinics, supporting Saudi Arabia's efforts to address demographic healthcare challenges. The firm has a history of developing healthcare services in the region and aims to scale further with this investment.PR NewswireBaraya Extended Care Closes Series B Funding Round Bringing Total Capital Raised to USD 124 Million from TVM Capital Healthcare and a Syndicate of Prominent InvestorsTVM Capital Healthcare completed an oversubscribed Series B funding round for Baraya Extended Care, raising more than its target to a total of USD 124 million. The funding aims to expand long-term care facilities in Saudi Arabia, addressing rising demand driven by demographic and health sector changes. The investment supports Baraya’s growth plans, including new inpatient and outpatient facilities, and has potential for use in other markets.